# Viri Sode

NDC: 83027-0304
Generic name: Cytomegalovirus Nosode, Herpes Simplex I and II Nosode, Influenzinum, Rubella Nosode, Hepatitis A Nosode, Hepatitis B Nosode, Hepatitis C Nosode, Epstein-Barr Virus Nosode, Herpes Zoster Nosode
Labeler / Manufacturer: Nutritional Specialties, Inc.
Product type: HUMAN OTC DRUG
Marketing category: UNAPPROVED HOMEOPATHIC
Dosage form: SPRAY
Routes: ORAL
Marketing started: 20260518



## Active ingredients

- HUMAN HERPESVIRUS 5: 16 [hp_X]/mL
- HUMAN HERPESVIRUS 1: 30 [hp_X]/mL
- HUMAN HERPESVIRUS 2: 30 [hp_X]/mL
- INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED): 15 [hp_C]/mL
- INFLUENZA A VIRUS A/THAILAND/8/2022 IVR-237 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED): 15 [hp_C]/mL
- INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 WHOLE: 15 [hp_C]/mL
- INFLUENZA B VIRUS B/PHUKET/3073/2013 BVR-1B WHOLE: 15 [hp_C]/mL
- RUBELLA VIRUS: 16 [hp_X]/mL
- HEPATITIS A VIRUS: 30 [hp_X]/mL
- HEPATITIS B VIRUS: 30 [hp_X]/mL
- HEPATITIS C VIRUS: 30 [hp_X]/mL
- HUMAN HERPESVIRUS 4: 15 [hp_C]/mL
- HUMAN HERPESVIRUS 3: 15 [hp_C]/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"83027-0304"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=83027-0304
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8fb280d9-b79f-4b44-a534-89ddda0c2778